Share on LinkedInShare on LinkedIn

ARTICLE · 05 MARCH 2024

Cannabis In 2024: HHS Rescheduling Recommendation And SAFER Banking

Akin
Akin
Contributor
Akin

Akin

Akin is a global law firm with more than 1,100 lawyers and advisors who pride themselves on...

View firm profile
Explore more from Akin

On August 29, 2023, the U.S. Department of Health and Human Services (HHS) issued a recommendation to the U.S. Drug Enforcement Administration (DEA)...

United StatesCannabis & Hemp

Key Points

  • The scientific review supporting HHS's recommendation to DEA that cannabis be reclassified from a Schedule I to a Schedule III drug was published on January 12, 2024.
  • Classifying cannabis as a Schedule III substance would have significant implications for state-legal cannabis businesses, including eliminating certain tax burdens for state-legal businesses and easing research restrictions. DEA continues to review the recommendation and potentially initiate a rulemaking process that includes a public comment period before any scheduling action is finalized.
  • The Senate continues to labor over the SAFER Banking Act (2860). Enactment of the Act would ensure that state-legal cannabis businesses have access to banking services.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from